Skip to main content
Impact Reports

Impact Report

Quarterly reports on how philanthropic support is fueling innovation at MSK, making an impact on the lives of cancer patients around the world.

Donate

Winter 2019

MSK Pediatrics

MSK Kids

Every year, nearly 16,000 children and teens in the United States are diagnosed with cancer. MSK is home to the largest pediatric oncology program in the country — and treats more kids with cancer than any other hospital nationwide.

Scarlett James

Meet Scarlett James

Scarlett James was a fun-loving six-year-old when she was diagnosed at MSK with a pediatric cancer known as T cell lymphoblastic lymphoma in 2013.

Dr. Andrew Kung

A Visit with Andrew Kung

Thanks to pioneering research by MSK and others, today 80 percent of children with cancer will be cured. Our goal is to drive that number higher, and with great urgency, which is why Department of Pediatrics Chair Andrew Kung, MD, PhD, has launched new programs to save the lives of more kids and minimize the long-term effects of cancer treatment.

Fall 2018

A 21st Century Bone Marrow Transplant

A 21st Century Bone Marrow Transplant

Beginning in the 1970s, bone marrow transplants (BMTs) have offered a chance of cure for many people with leukemias, lymphomas, and other blood disorders. An allogeneic BMT replaces a patient’s suppressed immune system with a new, healthy one — grown from donor stem cells or bone marrow. While BMTs are successful in 60 to 70 percent of patients, the procedure carries significant risk — including graft-versus-host disease (GVHD), which can occur when the newly transplanted cells attack the “foreign” host tissue. 

Jay O'Brien

Meet Jay O'Brien

I was a college athlete and coach, and I’ve always been in good shape. I also worked in the athletic footwear business for a long time.

In 2008, my wife and I were on one of our long walks, and I couldn’t make it up a hill. My heart was pounding like crazy — but I wasn’t sweating. I saw my primary care doctor in New Jersey.

The moment he saw me he was so concerned that he ordered blood work immediately. That afternoon, his office called — go to the ER. And that’s where my wife and I learned I had leukemia.

Marcel van den Brink

A Visit with Marcel van den Brink

Meet Marcel van den Brink, MD, PhD, whose research includes optimizing gut microbiota — the bacteria, or flora, that live in the gut — to improve outcomes following BMT. He also develops cell therapies to strengthen the immune system after transplant. While primarily focused on BMT, Dr. van den Brink’s work holds potential against many diseases.

Summer 2018

Outsmarting Lung Cancer

Outsmarting Lung Cancer

Lung cancer is one of the most difficult cancers to detect, and therefore to treat. But MSK physicians and scientists are introducing new approaches, called immunotherapies, which can help some lung cancer patients defeat the disease. Because of thoughtful donors like you, people are living beyond cancer.

Steve Cara

Reversing Cancer: Steve's Story

Apparel industry executive Steve Cara was 52 years old when he learned from his insurance agent that he had cancer. He had just taken a blood test to increase his life policy’s value. The diagnosis: lung cancer.

Matthew Hellmann, MD

A Visit with Matthew Hellmann

Lung cancer is still the leading cause of all deaths from cancer in the country and worldwide. Many patients with lung cancers have never smoked. Fortunately, new medicines such as immunotherapies are beginning to provide hope for patients with these diseases.